CHU Saint Etienne Hôpital Nord — Clinical Trial Site

8 Registered trials

4 Currently recruiting

Organisation

CHU Saint Etienne Hôpital Nord

Location

Saint Etienne, France

Identifier

ORL-000008316

Address

Av. Albert Raimond, 42055, France

Departments

Gastro-entérologie Hépatologie
Gynécologie Obstétrique
NEUROLOGIE
Onco-Hématologie pédiatrique
Oncology for pediatrics
Pediatric Hematology and Oncology
Pediatric oncology department
Pôle mère enfant-Unité Hématologie - Oncologie pédiatrique

Clinical trials at this site (8)

Search interface

IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending

2023-509392-17-00 Relapsed Acute Lymphoblastic Leukemia (ALL) 5
CAALL-F01: a French protocol for the treatment of acute lymphoblastic leukemia (ALL) in children and adolescents Pending

2024-514243-29-01 This is a prospective, French, multicenter, open-label, 5
Comparison of two prophylactic antibiotic regimens in case of preterm prelabor rupture of membranes before 34 weeks of gestation: a randomiz… Pending

2025-520842-31-00 Population of study participants Pregnant women with PP 5
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/o… Recruiting

2024-511862-35-00 Adults with non-contrast-enhancing diffuse brainstem gl 4 2019-07-19
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenan… Ended

2024-513569-38-00 Crohn's Disease 10 2021-07-09